Clinical Trial Update: 4 Consecutive Days on Treatment Followed by 3 Days Off Treatment, in HIV Patients [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial in HIV infection reports a dosing schedule of 4 days on treatment followed by 3 days off; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV-1 Infection | Phase 3 | Status: COMPLETED